The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The oral thin films market has undergone remarkable growth in recent years, with the market size surging from $4.07 billion in 2023 to $4.6 billion in 2024, marking a noteworthy compound annual growth rate (CAGR) of 13.0%. This upward trajectory is set to continue, projecting a robust market size of $7.65 billion by 2028, fueled by a CAGR of 13.6%. The market’s historic growth can be attributed to factors like patient compliance, pediatric and geriatric preferences, rapid drug delivery, the prevalence of chronic diseases, and the popularity of over-the-counter (OTC) medications.

Factors Driving Growth in the Historic Period

• Patient compliance
• Pediatric and geriatric preferences
• Rapid drug delivery
• Chronic diseases
• Over-the-counter (OTC) medications

Factors Propelling Growth in the Forecast Period

• Specialty pharmaceuticals
• Precision medicine
• Mental health medications
• Oral vaccines
• Telemedicine services

Major Trends in the Forecast Period

• Drug delivery technologies
• Remote care
• Bioavailability enhancement
• Travel and on-the-go usage
• Allergen-free formulations

Rising Demand for Thin Film Drug Delivery Systems

The surge in demand for thin film drug delivery systems is a driving force behind the oral thin films market’s growth. Thin films are emerging as a versatile alternative to conventional dosage forms, offering a convenient, self-administrable, and fast-dissolving option for medication delivery. The oral thin film’s appeal lies in its patient-friendly nature, thanks to its rapid dissolution rate and the fact that it doesn’t require water for swallowing. Notably, the global thin-film pharmaceutical products market is predicted to grow from $7 billion in 2015 to over $15 billion by the end of 2024, reflecting a substantial increase of 117% in a decade.

Key Players Shaping the Landscape

Several major companies play a pivotal role in driving the oral thin films market:

• ZIM Laboratories Limited
• NAL Pharma
• Cure Pharmaceutical Holding Corp.
• IntelGenx Corp.
• Kyu Kyu Pharmaceutical Co. Ltd.
• And many more…

View More On The Oral Thin Films Market Report 2024 – https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report

Focus on Product Innovations for Enhanced Services

Leading companies in the oral thin films market are prioritizing product innovations to offer reliable services to their customers. A standout example is IntelGenx Technologies Corp., a Canadian pharmaceutical company that introduced Rizaport in September 2021. Rizaport is an oral thin-film formulation containing rizatriptan benzoate, known for its efficacy in treating migraines. This innovative film administration method, which dissolves quickly in the tongue without the need for swallowing or water, presents a therapeutic alternative for migraine patients, especially those with difficulty swallowing or migraine-related nausea.

Strategic Acquisitions: Enhancing Expertise in Drug Delivery Systems

In a strategic move in September 2022, LTS LOHMANN Therapie-Systeme AG, a Germany-based company, acquired Tapemark Inc., a US-based Contract Development and Manufacturing Organization (CDMO). This acquisition significantly bolstered LTS’s expertise in drug delivery systems, particularly in the realm of oral thin films. Tapemark Inc., renowned for its excellence in transdermal drug delivery systems and oral thin films, further solidifies LTS’s position in the market.

Comprehensive Market Segmentation

The oral thin films market is comprehensively segmented for a nuanced understanding:

1. By Type:
   • Sublingual Film
   • Fast Dissolving Dental/Buccal Film
2. By Disease Indication:
   • Schizophrenia
   • Migraine
   • Opioid Dependence
   • Nausea & Vomiting
   • Other Disease Indication
3. By Distribution Channel:
   • Hospital Pharmacies
   • Retail Pharmacies
   • Other Distribution Channels

Regional Dynamics

North America took the lead in the oral thin film market in 2023, while Asia-Pacific is anticipated to be the fastest-growing region in the forecast period. This shift highlights the global nature of the oral thin films market, emphasizing the need for innovative drug delivery solutions on a worldwide scale.

In conclusion, the oral thin films market is experiencing unprecedented growth, driven by factors such as rising demand for thin film drug delivery systems, a focus on product innovations, and strategic acquisitions. As the market continues to evolve with technological advancements and patient-centric solutions, it holds the promise of revolutionizing drug delivery in diverse therapeutic areas.

Request A Sample Of The Global Oral Thin Films Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6067&type=smp